All results

8 results for smell loss and covid 19 study

• Kinect-HD2

  This is a Phase 3, open-label study to evaluate the long-term safety and tolerability of valbenazine, and to provide participants continued access to…

  Ages

  18 Years - 75 Years

  Sexes

  All

• XTMab

  A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis ### Inclusion Criteria: 1. Participant between 18 to 80 years (inclusive) of age. 2.…

  Ages

  18 Years - 80 Years

  Sexes

  All

• TN-31 JAKPOT T1D

  A multi-center, placebo-controlled, double blind, 1:1:1 randomized control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and…

  Ages

  12 Years - 35 Years

  Sexes

  All

• Fasting ENHANCE

  Grounded in the principles of geroscience, the proposed Fasting ENHANCE study will test whether a time restricted eating (TRE) regimen can improve cognitive…

  Ages

  65 Years - N/A

  Sexes

  All

• Addition of Pembrolizumab to Usual Intravesical Gemcitabine for Treatment of BCG-Unresponsive NMIBC

  This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does…

  Ages

  18 Years - N/A

  Sexes

  All

• SMART

  The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter…

  Ages

  18 Years - N/A

  Sexes

  All

• GCAptAIN

  This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell…

  Ages

  50 Years - N/A

  Sexes

  All

• A Study of ASP1002 in Adults for Treatment of Solid Tumors

  ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…

  Ages

  18 Years - N/A

  Sexes

  All